Prolight Diagnostics AB (NGM:PRLD) 1-Year ROIIC % : -306.96% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:PRLD Prolight Diagnostics AB NGM:PRLD
31 GF Score
Price kr17.90
! 1 Warning Sign
View Full Analysis

What is Prolight Diagnostics AB 1-Year ROIIC %?

Prolight Diagnostics AB NGM:PRLD +2.29% 31 1-Year ROIIC % is -306.96 as of Mar. 2026. GuruFocus rates NGM:PRLD with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 818 Medical Devices & Instruments companies, Prolight Diagnostics AB ranks worse than 92.91% on this metric.

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Prolight Diagnostics AB's 1-Year ROIIC % for the quarter that ended in Mar. 2026 was -306.96%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Prolight Diagnostics AB's 1-Year ROIIC % or its related term are showing as below:

NGM:PRLD's 1-Year ROIIC % is ranked worse than
92.91% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.745 vs NGM:PRLD: -306.96

Prolight Diagnostics AB  (NGM:PRLD) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Prolight Diagnostics AB 1-Year ROIIC % Related Terms


Prolight Diagnostics AB 1-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Prolight Diagnostics AB's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prolight Diagnostics AB 1-Year ROIIC % Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -195.03 -20.99 -68.67 59.49 291.33

Prolight Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.00 -1.02 89.82 291.33 -306.96

NGM:PRLD vs ISRG, BDX, MDLN: 1-Year ROIIC % Comparison

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB 1-Year ROIIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's 1-Year ROIIC % falls into.


NGM:PRLD
31GF Score
Prolight Diagnostics AB NGM:PRLD
1-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prolight Diagnostics AB 1-Year ROIIC % Calculation

Prolight Diagnostics AB's 1-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -44.6365 (Mar. 2026) - -28.911 (Mar. 2025) )/( 159.757 (Mar. 2026) - 154.634 (Mar. 2025) )
=-15.7255/5.123
=-306.96%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 1-Year ROIIC % →
What does a 1-Year ROIIC % of -306.96 mean?
Prolight Diagnostics AB (NGM:PRLD) has a 1-Year ROIIC % of -306.96 as of Mar. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Prolight Diagnostics AB and its competitors. According to the industry distribution chart, Prolight Diagnostics AB ranks #760 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 92.9%.
Is Prolight Diagnostics AB's 1-Year ROIIC % too high?
Prolight Diagnostics AB's current 1-Year ROIIC % is -306.96. Based on the distribution chart, Prolight Diagnostics AB ranks #760 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Prolight Diagnostics AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's 1-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prolight Diagnostics AB ranks #760 out of 818 companies for 1-Year ROIIC %. This places Prolight Diagnostics AB in the lower half of its industry. The industry median 1-Year ROIIC % is 0.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Medical Devices & Instruments company?
The median 1-Year ROIIC % among Medical Devices & Instruments companies is 0.75, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Prolight Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median 1-Year ROIIC % is 0.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolight Diagnostics AB's current 1-Year ROIIC % is -306.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (NGM:PRLD) has a current 1-Year ROIIC % of -306.96. The current 1-Year ROIIC % is -306.96. Prolight Diagnostics AB's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Prolight Diagnostics AB (NGM:PRLD), the current 1-Year ROIIC % is -306.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prolight Diagnostics AB Business Description

Address Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
31GF Score

Get the complete analysis for NGM:PRLD

1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.90
Price